Weight loss results At 68 weeks, the mean percent change in body weight was: Retatrutide 12 mg: -28.7% , equivalent to approximately 32.3 kg (71.2 lb) of absolute loss at baseline averages
In type 1 diabetes mellitus, DKD typically manifests as diabetic glomerulopathy, characterized by thickening of the glomerular basement membrane, mesangial matrix expansion, and hyalinosis affecting both afferent and efferent arterioles [21,22]
Separately, another study suggested that longer durations of GLP-1RA treatment may help sustain weight loss even after discontinuation, although this hypothesis remains to be validated
Both FDA-approved GLP-1 medications and many compounded versions qualify for HSA and flexible spending account reimbursement when prescribed by a licensed provider
Which specific weight loss medications are covered under your plans
Yepes-Corts, Isabel C